A non-contrast abdomino-pelvic/KUB CT scan is the preferred imaging modality for diagnosing nephrolithiasis in patients with a history of gout. This test has a high sensitivity and specificity and can also detect other pathologies.
Intravenous urography is less sensitive and requires IV contrast material, which can cause allergic reactions or renal failure.
Renal ultrasonography is useful in pregnancy or in combination with a KUB radiograph but is less accurate for diagnosing ureteral stones.
Retrograde ureterography is rarely performed for diagnostic purposes but is essential when surgery is necessary.
Uric acid stones are associated with low urine pH, high purine intake, or malignancy, and can be treated with allopurinol or alkali therapy depending on the patient’s uric acid levels.

Understanding Haemochromatosis: Symptoms, Causes, and Complications

Haemochromatosis is a genetic disorder that affects iron absorption and metabolism, leading to the accumulation of iron in the body. It is caused by mutations in the HFE gene on both copies of chromosome 6. This disorder is more common in people of European descent, with a prevalence of 1 in 200.

In the early stages of haemochromatosis, symptoms are often non-specific, such as fatigue and joint pain. As the disease progresses, patients may develop bronze skin pigmentation, diabetes mellitus, liver disease, cardiac failure, hypogonadism, and arthritis.

Treatment for haemochromatosis involves regular phlebotomy to remove excess iron from the body. Reversible complications of haemochromatosis include cardiomyopathy, skin pigmentation, liver cirrhosis, diabetes mellitus, hypogonadotrophic hypogonadism, and arthropathy. However, irreversible complications include cirrhosis, which can lead to liver failure and other serious health problems.

In conclusion, haemochromatosis is a genetic disorder that affects iron metabolism and can lead to serious health complications if left untreated. Early diagnosis and treatment can help prevent irreversible damage and improve quality of life for affected individuals.

Treatment Options for Acute Pericarditis

Acute pericarditis requires prompt treatment to prevent complications such as recurrent pericarditis, pericardial effusions, cardiac tamponade, and chronic constrictive pericarditis. The initial treatment for idiopathic or viral pericarditis involves high-dose non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin in combination with colchicine. The duration of NSAID or aspirin treatment depends on symptom resolution and normalization of C-reactive protein (CRP), while colchicine treatment is continued for three months using a low, weight-adjusted dose. Strenuous physical activity should be restricted until symptom resolution and normalization of inflammatory markers, and gastroprotection with a proton-pump inhibitor is recommended.

If NSAIDs and colchicine are contraindicated, low-dose corticosteroids are the next step in the treatment algorithm, after exclusion of infectious causes. However, when the cause of the pericarditis is known, it must be treated first before starting anti-inflammatory treatment.

Managing Acute Pericarditis: Treatment Options and Considerations

Angiotensin-converting enzyme (ACE) inhibitors are commonly used as the first-line treatment for hypertension and heart failure in younger patients. However, they may not be as effective in treating hypertensive Afro-Caribbean patients. These inhibitors are also used to treat diabetic nephropathy and for secondary prevention of ischaemic heart disease. The mechanism of action of ACE inhibitors is to inhibit the conversion of angiotensin I to angiotensin II. They are metabolized in the liver through phase 1 metabolism.

ACE inhibitors may cause side effects such as cough, which occurs in around 15% of patients and may occur up to a year after starting treatment. This is thought to be due to increased bradykinin levels. Angioedema may also occur up to a year after starting treatment. Hyperkalaemia and first-dose hypotension are other potential side effects, especially in patients taking diuretics. ACE inhibitors should be avoided during pregnancy and breastfeeding, and caution should be exercised in patients with renovascular disease, aortic stenosis, or hereditary or idiopathic angioedema.

Patients receiving high-dose diuretic therapy (more than 80 mg of furosemide a day) are at an increased risk of hypotension when taking ACE inhibitors. Before initiating treatment, urea and electrolytes should be checked, and after increasing the dose, a rise in creatinine and potassium may be expected. Acceptable changes include an increase in serum creatinine up to 30% from baseline and an increase in potassium up to 5.5 mmol/l. Patients with undiagnosed bilateral renal artery stenosis may experience significant renal impairment. The current NICE guidelines provide a flow chart for the management of hypertension.

Snoring is not a symptom of Kallman’s syndrome, which is a condition that leads to delayed puberty due to hypogonadotrophic hypogonadism.

Snoring in Children: Possible Causes

Snoring in children can be caused by various factors. One of the common causes is obesity, which can lead to the narrowing of the airways and difficulty in breathing during sleep. Another possible cause is nasal problems such as polyps, deviated septum, and hypertrophic nasal turbinates, which can also obstruct the airways and cause snoring. Recurrent tonsillitis can also contribute to snoring, as the inflamed tonsils can block the air passages.

In some cases, snoring in children may be associated with certain medical conditions such as Down’s syndrome and hypothyroidism. These conditions can affect the structure and function of the respiratory system, leading to snoring and other breathing difficulties.

It is important to identify the underlying cause of snoring in children and seek appropriate treatment to prevent potential health complications. Parents should consult a healthcare professional if their child snores regularly or experiences other symptoms such as daytime sleepiness, difficulty concentrating, or behavioral problems.

Doxycycline is the recommended treatment for chlamydia.

Chlamydia is a common sexually transmitted infection caused by Chlamydia trachomatis. It is prevalent in the UK, with approximately 1 in 10 young women affected. The incubation period is around 7-21 days, but many cases are asymptomatic. Symptoms in women include cervicitis, discharge, and bleeding, while men may experience urethral discharge and dysuria. Complications can include epididymitis, pelvic inflammatory disease, and infertility.

Traditional cell culture is no longer widely used for diagnosis, with nuclear acid amplification tests (NAATs) being the preferred method. Testing can be done using urine, vulvovaginal swab, or cervical swab. Screening is recommended for sexually active individuals aged 15-24 years, and opportunistic testing is common.

Doxycycline is the first-line treatment for Chlamydia, with azithromycin as an alternative if doxycycline is contraindicated or not tolerated. Pregnant women may be treated with azithromycin, erythromycin, or amoxicillin. Patients diagnosed with Chlamydia should be offered partner notification services, with all contacts since the onset of symptoms or within the last six months being notified and offered treatment.

Necrobiosis lipoidica diabeticorum is a condition characterized by waxy yellow shin lesions that often occur in individuals with diabetes.

Understanding Shin Lesions: Differential Diagnosis and Characteristic Features

Shin lesions can be caused by a variety of conditions, and it is important to differentiate between them in order to provide appropriate treatment. The four most common conditions that can cause shin lesions are erythema nodosum, pretibial myxoedema, pyoderma gangrenosum, and necrobiosis lipoidica diabeticorum.

Erythema nodosum is characterized by symmetrical, tender, erythematous nodules that heal without scarring. It is often caused by streptococcal infections, sarcoidosis, inflammatory bowel disease, or certain medications such as penicillins, sulphonamides, or oral contraceptive pills.

Pretibial myxoedema, on the other hand, is seen in Graves’ disease and is characterized by symmetrical, erythematous lesions that give the skin a shiny, orange peel appearance.

Pyoderma gangrenosum initially presents as a small red papule, which later develops into deep, red, necrotic ulcers with a violaceous border. It is idiopathic in 50% of cases, but may also be seen in inflammatory bowel disease, connective tissue disorders, and myeloproliferative disorders.

Finally, necrobiosis lipoidica diabeticorum is characterized by shiny, painless areas of yellow/red skin typically found on the shin of diabetics. It is often associated with telangiectasia.

In summary, understanding the differential diagnosis and characteristic features of shin lesions can help healthcare professionals provide appropriate treatment and improve patient outcomes.

Common Pediatric Diseases: Symptoms and Management

Henoch–Schönlein purpura (HSP), Acute lymphocytic leukaemia, Alport’s syndrome, and Juvenile rheumatoid arthritis (JRA) are some of the common pediatric diseases that require prompt diagnosis and management. HSP is an autoimmune hypersensitivity vasculitis that often affects children and is associated with IgA dominant immune complexes. ALL is a type of cancer that affects the blood and bone marrow, causing symptoms such as fatigue, fever, and joint pain. Alport’s syndrome is a hereditary nephritis that can lead to chronic kidney disease, hearing loss, and ocular abnormalities. JRA is characterized by swollen joints, fever, and joint pain. Prompt diagnosis and management are crucial in these diseases, which may require supportive treatment, pain relief, and monitoring for potential complications.

GBS bacteriuria is linked to an increased risk of chorioamnionitis and neonatal sepsis, therefore, the Royal College of Obstetricians and Gynaecologists recommends that women with GBS bacteriuria should receive intrapartum antibiotics along with appropriate treatment upon diagnosis. In cases where the patient is not allergic to penicillin, intravenous benzylpenicillin should be administered as soon as possible after the onset of labor and then every 4 hours until delivery. Postnatal antibiotic treatment is not necessary unless there are indications of neonatal infection. Caesarean section is not recommended. [RCOG Green-top Guideline No. 36]

Group B Streptococcus (GBS) is a common cause of severe infection in newborns. It is estimated that 20-40% of mothers carry GBS in their bowel flora, which can be passed on to their infants during labor and lead to serious infections. Prematurity, prolonged rupture of membranes, previous sibling GBS infection, and maternal pyrexia are all risk factors for GBS infection. The Royal College of Obstetricians and Gynaecologists (RCOG) has published guidelines on GBS management, which include not offering universal screening for GBS to all women and not offering screening based on maternal request. Women who have had GBS detected in a previous pregnancy should be offered intrapartum antibiotic prophylaxis (IAP) or testing in late pregnancy and antibiotics if still positive. IAP should also be offered to women with a previous baby with GBS disease, women in preterm labor, and women with a fever during labor. Benzylpenicillin is the preferred antibiotic for GBS prophylaxis.

Treatment Options for Latent Tuberculosis

Latent tuberculosis is a disease that can remain dormant in the body for years without causing any symptoms. However, if left untreated, it can develop into active tuberculosis, which can be life-threatening. To prevent this from happening, NICE now offers two choices for treating latent tuberculosis.

The first option is a combination of isoniazid (with pyridoxine) and rifampicin for three months. This is recommended for people under the age of 35 who are concerned about the hepatotoxicity of the drugs. Before starting this treatment, a liver function test is conducted to assess the risk factors.

The second option is a six-month course of isoniazid (with pyridoxine) for people who are at risk of interactions with rifamycins. This includes individuals with HIV or those who have had a transplant. The risk factors for developing active tuberculosis include silicosis, chronic renal failure, HIV positivity, solid organ transplantation with immunosuppression, intravenous drug use, haematological malignancy, anti-TNF treatment, and previous gastrectomy.

In summary, the choice of treatment for latent tuberculosis depends on the individual’s clinical circumstances and risk factors. It is important to consult with a healthcare professional to determine the best course of action.

Typical symptoms of carbon monoxide poisoning include confusion and pink mucosae, with a low-grade fever being present in only a small number of cases.

Understanding Carbon Monoxide Poisoning

Carbon monoxide poisoning occurs when carbon monoxide, a toxic gas, is inhaled and binds to haemoglobin and myoglobin in the body, resulting in tissue hypoxia. This leads to a left-shift of the oxygen dissociation curve, causing a decrease in oxygen saturation of haemoglobin. In the UK, there are approximately 50 deaths per year from accidental carbon monoxide poisoning.

Symptoms of carbon monoxide toxicity include headache, nausea and vomiting, vertigo, confusion, and subjective weakness. Severe toxicity can result in pink skin and mucosae, hyperpyrexia, arrhythmias, extrapyramidal features, coma, and even death.

To diagnose carbon monoxide poisoning, pulse oximetry may not be reliable due to similarities between oxyhaemoglobin and carboxyhaemoglobin. Therefore, a venous or arterial blood gas should be taken to measure carboxyhaemoglobin levels. Non-smokers typically have levels below 3%, while smokers have levels below 10%. Symptomatic patients have levels between 10-30%, and severe toxicity is indicated by levels above 30%. An ECG may also be useful to check for cardiac ischaemia.

In the emergency department, patients with suspected carbon monoxide poisoning should receive 100% high-flow oxygen via a non-rebreather mask. This decreases the half-life of carboxyhemoglobin and should be administered as soon as possible, with treatment continuing for a minimum of six hours. Target oxygen saturations are 100%, and treatment is generally continued until all symptoms have resolved. For more severe cases, hyperbaric oxygen therapy may be considered, as it has been shown to have better long-term outcomes than standard oxygen therapy. Indications for hyperbaric oxygen therapy include loss of consciousness, neurological signs other than headache, myocardial ischaemia or arrhythmia, and pregnancy.

Overall, understanding the pathophysiology, symptoms, and management of carbon monoxide poisoning is crucial in preventing and treating this potentially deadly condition.

Managing Vitiligo: Recommended Treatments and Precautions

Vitiligo is a skin condition that requires careful management to prevent further damage and reduce the risk of skin cancer. Daily application of sunscreen to affected areas is crucial due to increased susceptibility to UV-light-induced damage. Camouflaging makeup can also help alleviate psychological distress. Topical steroids are recommended for up to two months, and if there is no response, a referral to a dermatologist is necessary. Emollients and oral antihistamines are not useful in vitiligo management. Oral steroids are rarely used, and topical clotrimazole and dapsone are not first-line treatments. Topical tacrolimus and phototherapy may have a role, but caution is needed for light-skinned patients. Overall, early intervention and precautionary measures are key to managing vitiligo effectively.

Bartter’s syndrome is a genetic condition that typically follows an autosomal recessive pattern of inheritance. It results in severe hypokalaemia due to a defect in the absorption of chloride at the Na+ K+ 2Cl- cotransporter in the ascending loop of Henle. Unlike other endocrine causes of hypokalaemia such as Conn’s, Cushing’s and Liddle’s syndrome, Bartter’s syndrome is associated with normotension. The condition usually presents in childhood and is characterized by symptoms such as failure to thrive, polyuria, polydipsia, hypokalaemia, and weakness.

Hypertension, or high blood pressure, can also affect children. To measure blood pressure in children, it is important to use a cuff size that is approximately 2/3 the length of their upper arm. The 4th Korotkoff sound is used to measure diastolic blood pressure until adolescence, when the 5th Korotkoff sound can be used. Results should be compared with a graph of normal values for their age.

In younger children, secondary hypertension is the most common cause, with renal parenchymal disease accounting for up to 80% of cases. Other causes of hypertension in children include renal vascular disease, coarctation of the aorta, phaeochromocytoma, congenital adrenal hyperplasia, and essential or primary hypertension, which becomes more common as children get older. It is important to identify the underlying cause of hypertension in children in order to provide appropriate treatment and prevent complications.

Bumetanide is the only medication among the options that may cause ototoxicity, marked by hearing loss. This loop diuretic is used to manage heart failure by inhibiting the Na+-K+-Cl- cotransporter in the thick ascending limb of the loop of Henle, reducing the absorption of NaCl. However, at high levels, it may also inhibit the Na+-K+-Cl- cotransporter in the inner ear, damaging the hair cells and decreasing endolymph. Amlodipine, bisoprolol, and ramipril are not known to cause ototoxicity and are used to manage hypertension and heart failure.

Loop Diuretics: Mechanism of Action and Indications

Loop diuretics, such as furosemide and bumetanide, are medications that inhibit the Na-K-Cl cotransporter (NKCC) in the thick ascending limb of the loop of Henle. This reduces the absorption of NaCl and increases the excretion of water and electrolytes, making them effective in treating conditions such as heart failure and resistant hypertension. Loop diuretics act on NKCC2, which is more prevalent in the kidneys.

As loop diuretics work on the apical membrane, they must first be filtered into the tubules by the glomerulus before they can have an effect. This means that patients with poor renal function may require higher doses to achieve a sufficient concentration within the tubules.

Loop diuretics are commonly used in the treatment of heart failure, both acutely (usually intravenously) and chronically (usually orally). They are also effective in treating resistant hypertension, particularly in patients with renal impairment.

However, loop diuretics can have adverse effects, including hypotension, hyponatremia, hypokalemia, hypomagnesemia, hypochloremic alkalosis, ototoxicity, hypocalcemia, renal impairment (from dehydration and direct toxic effect), hyperglycemia (less common than with thiazides), and gout.

In summary, loop diuretics are effective medications for treating heart failure and resistant hypertension, but their use should be carefully monitored due to potential adverse effects. Patients with poor renal function may require higher doses to achieve therapeutic effects.

For an unwell child with suspected meningitis who is over 3 months old, the recommended initial empirical therapy is IV 3rd generation cephalosporin, such as ceftriaxone. IV cefuroxime, a 2nd generation cephalosporin, is not recommended for this purpose. IV cefotaxime + amoxicillin is recommended for babies at risk of jaundice, but as the child in this case is 4 months old, this is not necessary. IV co-amoxiclav and piperacillin do not provide adequate coverage for meningitis and are not suitable for central nervous system infections.

Investigation and Management of Meningitis in Children

Meningitis is a serious condition that can affect children. When investigating meningitis, it is important to note any contraindications to lumbar puncture, such as signs of raised intracranial pressure, focal neurological signs, papilloedema, significant bulging of the fontanelle, disseminated intravascular coagulation, or signs of cerebral herniation. For patients with meningococcal septicaemia, a lumbar puncture is contraindicated, and blood cultures and PCR for meningococcus should be obtained instead.

The management of meningitis in children involves administering antibiotics, such as IV amoxicillin (or ampicillin) and IV cefotaxime for children under three months, and IV cefotaxime (or ceftriaxone) for children over three months. Steroids should be considered if the lumbar puncture reveals certain findings, such as purulent cerebrospinal fluid, a high white blood cell count, or bacteria on Gram stain. Fluids should be administered to treat shock, and cerebral monitoring should be conducted, including mechanical ventilation if necessary.

It is also important to notify public health authorities and administer antibiotic prophylaxis to contacts. Ciprofloxacin is now preferred over rifampicin for this purpose. Overall, prompt and appropriate management of meningitis in children is crucial for ensuring the best possible outcomes.

Acromegaly is a medical condition caused by hypersecretion of growth hormone, which can lead to various health problems. One of the associated conditions is diabetes mellitus, as acromegaly is often linked with insulin resistance. Another condition is acanthosis nigricans, which involves hyperpigmentation of the skin. However, there is no general pigmentation associated with acromegaly.

Cardiovascular disease is also a common association, which can increase the risk of atrial fibrillation. Left ventricular hypertrophy is another condition that can occur with acromegaly.

Finally, ulnar nerve entrapment is not directly associated with acromegaly, but carpal tunnel syndrome affecting the median nerve is a common association.

The initial and most important treatment for blepharitis, a common and chronic condition, is regular lid hygiene. Although there are different types of blepharitis, lid hygiene is the first-line treatment for all of them. The goal is to clear out any stagnant oily secretions, unblock meibomian glands, remove bacteria and flakes of skin, and soothe the eyelids. Patients should practice lid hygiene twice daily, which involves warmth, massage, and cleansing. There are many patient information leaflets available online that explain the process. Oral tetracycline is not the first-line treatment for blepharitis and is usually unnecessary if lid hygiene measures are followed. If symptoms persist, a course of oral tetracycline may be considered, especially in cases where meibomian gland dysfunction is prominent and there is associated rosacea. Sodium cromoglicate eye drops are not used in the management of blepharitis, as they are intended for allergic eye disease. Steroid eye drops are not a primary care treatment option for blepharitis and are not first-line, although they may be considered by specialists in cases resistant to other treatment measures.

Blepharitis is a condition where the eyelid margins become inflamed. This can be caused by dysfunction of the meibomian glands (posterior blepharitis) or seborrhoeic dermatitis/staphylococcal infection (anterior blepharitis). It is more common in patients with rosacea. The meibomian glands secrete oil to prevent rapid evaporation of the tear film, so any problem affecting these glands can cause dryness and irritation of the eyes. Symptoms of blepharitis are usually bilateral and include grittiness, discomfort around the eyelid margins, sticky eyes in the morning, and redness of the eyelid margins. Styes and chalazions are also more common in patients with blepharitis, and secondary conjunctivitis may occur.

Management of blepharitis involves softening the lid margin with hot compresses twice a day and practicing lid hygiene to remove debris from the lid margins. This can be done using cotton wool buds dipped in a mixture of cooled boiled water and baby shampoo or sodium bicarbonate in cooled boiled water. Artificial tears may also be given for symptom relief in people with dry eyes or an abnormal tear film.

It is probable that the patient is suffering from malignant otitis externa, a condition that affects individuals with weakened immune systems like those with diabetes. This condition is characterized by osteomyelitis of the temporal bone. Despite receiving several rounds of antibiotic drops, the patient’s symptoms have not improved. It is recommended that the patient be referred to an ENT specialist for a CT scan of the temporal bones and treated with an extended course of intravenous antibiotics.

Understanding Otitis Externa: Causes, Features, and Management

Otitis externa is a common condition that often prompts patients to seek medical attention. It is characterized by ear pain, itch, and discharge, and is caused by various factors such as infection, seborrhoeic dermatitis, and contact dermatitis. Swimming is also a common trigger of otitis externa. Upon examination, the ear canal appears red, swollen, or eczematous.

The recommended initial management of otitis externa involves the use of topical antibiotics or a combination of topical antibiotics with a steroid. However, if the tympanic membrane is perforated, aminoglycosides are traditionally not used. In cases where there is canal debris, removal may be necessary, while an ear wick may be inserted if the canal is extensively swollen. Second-line options include oral antibiotics, taking a swab inside the ear canal, and empirical use of an antifungal agent.

It is important to note that if a patient fails to respond to topical antibiotics, referral to an ENT specialist may be necessary. Malignant otitis externa is a more serious condition that is more common in elderly diabetics. It involves the extension of infection into the bony ear canal and the soft tissues deep to the bony canal, and may require intravenous antibiotics.

Overall, understanding the causes, features, and management of otitis externa is crucial in providing appropriate care and preventing complications.

If a baby was in a breech presentation, it is important to ensure that they have been referred for screening for developmental dysplasia of the hip (DDH) as it is a risk factor for this condition. The Department of Health recommends that all babies who were breech at any point from 36 weeks (even if not breech at birth), babies born before 36 weeks who were in a breech presentation, and all babies with a first degree relative who had a hip problem in early life, should undergo ultrasound screening for hip dysplasia. If one twin was breech, both should be screened. Some hospitals also refer babies with other conditions such as oligohydramnios, high birth weight, torticollis, congenital talipes calcaneovalgus, and metatarsus adductus for screening. For more information on screening for DDH, please refer to the link provided.

Developmental dysplasia of the hip (DDH) is a condition that affects 1-3% of newborns and is more common in females, firstborn children, and those with a positive family history or breech presentation. It used to be called congenital dislocation of the hip (CDH). DDH is more often found in the left hip and can be bilateral in 20% of cases. Screening for DDH is recommended for infants with certain risk factors, and all infants are screened using the Barlow and Ortolani tests at the newborn and six-week baby check. Clinical examination includes testing for leg length symmetry, restricted hip abduction, and knee level when hips and knees are flexed. Ultrasound is used to confirm the diagnosis if clinically suspected, but x-ray is the first line investigation for infants over 4.5 months. Management includes the use of a Pavlik harness for children under 4-5 months and surgery for older children with unstable hips.

The patient’s symptoms are consistent with necrotizing fasciitis, which often affects the perineum. The patient is experiencing severe pain, which may be causing his fever and rapid heart and breathing rates. As a type 2 diabetic taking dapagliflozin, an SGLT-2 inhibitor, his risk of developing necrotizing fasciitis is increased. While cellulitis can have similar symptoms in the early stages, the presence of bullae, purple discoloration, and severe pain in a patient with risk factors for necrotizing fasciitis make it less likely. Septic arthritis is not a likely diagnosis as it affects joint spaces, which is not the case in this patient. Pyoderma gangrenosum, which is associated with inflammatory conditions, is not a likely diagnosis as the rash is not ulcerated and the patient has no history of inflammatory bowel disease or rheumatoid arthritis.

Understanding Necrotising Fasciitis

Necrotising fasciitis is a serious medical emergency that can be difficult to identify in its early stages. It can be classified into two types based on the causative organism. Type 1 is the most common and is caused by mixed anaerobes and aerobes, often occurring post-surgery in diabetics. Type 2 is caused by Streptococcus pyogenes. There are several risk factors associated with necrotising fasciitis, including recent trauma, burns, or soft tissue infections, diabetes mellitus, intravenous drug use, and immunosuppression. The most commonly affected site is the perineum, also known as Fournier’s gangrene.

The features of necrotising fasciitis include an acute onset, pain, swelling, and erythema at the affected site. It often presents as rapidly worsening cellulitis with pain that is out of keeping with physical features. The infected tissue is extremely tender and may have hypoaesthesia to light touch. Late signs include skin necrosis and crepitus/gas gangrene. Fever and tachycardia may be absent or occur late in the presentation.

Management of necrotising fasciitis requires urgent surgical referral for debridement and intravenous antibiotics. The prognosis for this condition is poor, with an average mortality rate of 20%. It is important to be aware of the risk factors and features of necrotising fasciitis to ensure prompt diagnosis and treatment.